46.46.Z - Wholesale trade of pharmaceutical and medical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.75.Z - Wholesale trade
46.76.Z - Wholesale trade
46.90.Z - Non-specialized wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 32,7 | 55 | 92,9 | 68,9 |
EBITDA | 35,6 | 50,8 | 89,6 | 76,4 |
Short time liabilities | 292 | 449,6 | 610,7 | 35,8 |
Equity capital | 62,4 | 81,1 | 113,6 | 40,1 |
Operating profit (EBIT) | 32,5 | 46,9 | 82,3 | 75,3 |
Assets | 361,2 | 556,3 | 746,3 | 34,2 |
Net profit (loss) | 29,1 | 44,2 | 76,7 | 73,6 |
Cash | 0 | 1,6 | 0,1 | -91,7 |
Liabilities and provisions for liabilities | 298,8 | 475,1 | 632,7 | 33,2 |
Net income from sale | 977,6 | 1377,7 | 1833,7 | 33,1 |
Working assets | 318,9 | 489,1 | 655,6 | 34 |
Depreciation | 3,2 | 3,9 | 7,4 | 90,1 |
% | % | % | p.p. | |
Profitability of capital | 46,6 | 54,5 | 67,5 | 13 |
Equity capital to total assets | 17,3 | 14,6 | 15,2 | 0,6 |
Gross profit margin | 3,3 | 4 | 5,1 | 1,1 |
EBITDA Margin | 3,6 | 3,7 | 4,9 | 1,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 109 | 119 | 122 | 3 |
Current financial liquidity indicator | 1.0727163553237915 | 1.0402536392211914 | 1.0486682653427124 | 0 |
Net dept to EBITDA | 0.779955267906189 | 1.0136561393737793 | 0.7766594290733337 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane